Subscribe

Dana Taylor

Authored Articles

Transplant Remains Best Upfront Treatment Option in Newly Diagnosed Myeloma
Dana Taylor
Hematologic Malignancies
April 2016, Vol 7, No 3
Read Article
Daratumumab Improves Overall Survival in Multiple Myeloma
Dana Taylor
Hematologic Malignancies, Multiple Myeloma
February 2016, Vol 7, No 1
Read Article
Consistent Benefit Over Time in Elotuzumab Studies
Dana Taylor
Hematologic Malignancies, Multiple Myeloma
February 2016, Vol 7, No 1
Read Article
All-Oral Regimen May Become a New Standard of Care in Advanced Multiple Myeloma
Dana Taylor
Hematologic Malignancies, Multiple Myeloma
February 2016, Vol 7, No 1
Read Article
Multiple Myeloma Therapy in 2015: “An Extraordinary Moment in Oncology”
Dana Taylor
Hematologic Malignancies, Multiple Myeloma
February 2016, Vol 7, No 1
Read Article
Rituximab Boosts Chemotherapy Benefit in Patients with B-Cell Precursor ALL
Dana Taylor
Hematologic Malignancies, Leukemia
March 2016, Vol 7, No 2
Read Article
Pembrolizumab Shows Promise in Multiple Myeloma
Dana Taylor
Hematologic Malignancies, Multiple Myeloma
March 2016, Vol 7, No 2
Read Article
First-in-Human CAR T-Cell Trial Demonstrates Activity in Multiple Myeloma
Dana Taylor
Emerging Therapies, Hematologic Malignancies, Multiple Myeloma, Personalized Medicine
March 2016, Vol 7, No 2
Read Article
A 3-Drug Regimen the Preferred Approach in Newly Diagnosed Multiple Myeloma
Dana Taylor
Hematologic Malignancies, Multiple Myeloma
March 2016, Vol 7, No 2
Read Article
Using Genetics to Guide Pembrolizumab Therapy in CRC
Dana Taylor
Emerging Therapies, Personalized Medicine
October 2015, Vol 6, No 9
Read Article
Assessing the Cost-Effectiveness of Necitumumab in Squamous-Cell Lung Cancer
Dana Taylor
Economics & Value, Economics of Cancer Care
August 2015, Vol 6, No 7
Read Article
Site of Service Significantly Impacts Cost of Chemotherapy
Dana Taylor
Economics & Value, Economics of Cancer Care
August 2015, Vol 6, No 7
Read Article
Dissecting the Cost of Targeted Therapies in Oncology
Dana Taylor
Economics & Value, Economics of Cancer Care, Targeted Therapy
August 2015, Vol 6, No 7
Read Article
Two Large National Personalized Medicine Clinical Trials Are Launched by ASCO and NCI
Dana Taylor
ASCO 2015 Highlights, ASCO
July 2015, Vol 6, No 6
Read Article
Current Cost of Cancer Drugs Does Not Reflect Value, One Oncologist Suggests
Dana Taylor
ASCO 2015 Highlights, ASCO
July 2015, Vol 6, No 6
Read Article
Olaparib-Carboplatin Combination Shows Promise for Patients with Ovarian or Triple-Negative Breast Cancer
Dana Taylor
AACR Meeting Highlights
May 2015, Vol 6, No 4
Read Article
Preventing Relapse in Myeloma Carries Economic Benefits, Reduces Overall Costs
Dana Taylor
Economics & Value, Economics of Cancer Care
March 2015, Vol 6, No 2
Read Article

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

© Amplity Health. All Rights Reserved. Privacy Policy.